RWS Holdings plc (RWS.L)
| Previous close | 166.60 |
| Open | 168.00 |
| Bid | 171.40 x 0 |
| Ask | 172.20 x 0 |
| Day's range | 166.20 - 173.60 |
| 52-week range | 157.20 - 284.40 |
| Volume | |
| Avg. volume | 1,799,741 |
| Market cap | 629.77M |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.12 (7.32%) |
| Ex-dividend date | 25 Jan 2024 |
| 1y target est | N/A |
- Business Wire
RWS Joins Meta’s Open Loop Program to Shape Future of AI Policy
CHALFONT ST PETER, England, April 22, 2024--RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, has joined forces with industry leaders to bridge the gap between rapid advances in AI innovation and policy-making through Meta’s Open Loop program.
- Business Wire
Component Content Alliance Sets New Standard in Content Development and Strategy
CHALFONT ST PETER, England, March 18, 2024--RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces the launch of the Component Content Alliance (CCA), a global community that brings together content experts, thought leaders and technical professionals to collaborate, share insights and drive innovation in component content development.
- Business Wire
Transform Pharmaceutical Authoring Processes With Fonto Integrated Authoring Platform
CHALFONT ST PETER, England, March 13, 2024--RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property solutions, announces the launch of the Fonto Integrated Authoring Platform (IAP), a game-changing solution designed to streamline the document creation and publishing process for the pharmaceutical industry.
